We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Software to Upgrade Sub-Saharan Blood Supply

By HospiMedica staff writers
Posted on 06 May 2004
The delivery of software to upgrade the blood supply in Sub-Saharan Africa has been announced by Global Med Technologies, Inc. More...
(Denver, CO, USA).

The two software programs were the SafeTrace donor management system and the SafeTrace Tx transfusion management system. Together they contribute to Vein-To-Vein tracking from donor collection to patient transfusion. Both are the products of Global Med's division, Wyndgate Technologies (Eldorado Hills, CA, USA; www.wyndgate.com). This delivery marks the beginning of Global Med's foray into international markets, where there are abundant opportunities to help underdeveloped countries upgrade their blood supply.

Blood centers are faced with blood shortages and an environment of possible contamination of the blood supply with blood-borne diseases, such as HIV, hepatitis, and West Nile Virus. These factors, especially the spread of HIV, are becoming drivers in the international market for blood center and transfusion services. Most blood banks and hospitals in sub-Saharan Africa utilize manual processes and maintain only manual records with little or no computer software or automation to help control the testing and safe release of blood and blood products.

Wyndgate's donor and hospital transfusion information systems, with their comprehensive safety features, will help to enhance the quality of blood products distributed throughout sub-Saharan Africa by helping to ensure that only suitable blood products are released for transfusion. Potentially, this may help to decrease the transmission rate of HIV/AIDS through blood transfusions in sub-Saharan Africa, which in turn may ultimately help to save many lives.

Mick Ruxin, M.D., chairman and CEO of Global Med Technologies stated, "This is truly a milestone for Global Med--something that the management team always believed would happen and which has the potential to catapult the company into many other countries to sell its medical software management systems.” Wyndgate has strategic marketing relationships with a number of companies in the blood services products industry. Through these partnerships, Global Med is poised to take advantage of expanded market opportunities for its blood services management software.





Related Links:
Global Med
Wyndgate

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.